Franklin Advisors
5
441M
4
0.13
0.20
2
- Stages of investment
- Areas of investment
Summary
Franklin Advisors is the famous Corporate Investor, which was founded in 1985. The main office of represented Corporate Investor is situated in the Farmington Hills. The company was established in North America in United States.
Among the most popular portfolio startups of the fund, we may highlight Aduro BioTech, Edge Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Biopharma.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Franklin Advisors, startups are often financed by Morningside Group, Maxim Group, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Janus Capital Group, Venrock, Sofinnova Investments. In the next rounds fund is usually obtained by Novartis.
The common things for fund are deals in the range of 50 - 100 millions dollars. The increased amount of exits for fund were in 2015. The important activity for fund was in 2015. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.13
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (4)
- Biopharma (3)
- Chemical (2)
- Health Care (1)
- Medical (1) Show 4 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Edge Therapeutics | 09 Apr 2015 | Biotechnology, Health Care, Medical | Late Stage Venture | 56M | United States, New Jersey |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.